BioSpace News Archive

Nexus Pharmaceuticals LLC announced it has received U.S. Food and Drug Administration (FDA) approval for 0.9% Sodium Chloride Injection, USP in 10mL and 20mL Single-Dose Vials.

RS BioTherapeutics has entered into a Research Collaboration Agreement with the National Institute on Alcohol Abuse and Alcoholism (NIAAA), an institute within the National Institutes of Health (NIH), to assess the anti-inflammatory and anti-fibrotic potential of RS BioTherapeutics’ lead compound, RSBT-001, in a preclinical pulmonary fibrosis model.

For the fourth year in a row, Crystal Clinic Orthopaedic Center was named one of America’s 100 Best Hospitals for Spine Surgery Excellence by Healthgrades, an online healthcare database that analyzes clinical outcomes in U.S. hospitals across 32 procedures and conditions.

BIOTRONIK, a leader in implantable medical device technology, today announced its first US implantation of the new Amvia Edge pacemaker.

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) (“MIRA” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of a novel synthetic THC analog, will host a virtual roadshow webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time.

Cerecin Inc. announced that new data on investigational CER-0001 in infantile spasms has been accepted for presentation at the 35th International Epilepsy Congress, held in Dublin, Ireland from September 2nd-6th 2023.

Kiora Pharmaceuticals (NASDAQ: KPRX) invites you to participate in a webinar highlighting the progress of molecular photoswitches in retinitis pigmentosa and the future

Spark Biomedical, Inc. was awarded a $1.15M Phase II grant to develop a Transcutaneous Auricular Neurostimulation device, Sparrow® Hawk, to address the adverse effects of acute stress reaction.

A new survey from the Association for Diagnostics & Laboratory Medicine found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives.

Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, will participate at the Morgan Stanley 21st Annual Global Healthcare Conference on September 12 at 12:35 p.m. P.T. / 3:35 p.m. E.T.